Wissenschaftliche Arbeiten

Doç. Dr. Alper Azak

100 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil

  1. Interstitial Fibrosis Severity Is Not Independently Associated with Anemia in Biopsy-Proven Primary Glomerulonephritis: A Nationwide Registry Analysis

    Medicina, 2026

    DOI 10.3390/medicina62050820 PMID 42195073 Frei zugänglicher VolltextQuelle: ORCID

  2. Glycaemic control and complications in haemodialysis patients: the TURK-HEMODIAB Study

    Clinical kidney journal, 2026

    DOI 10.1093/ckj/sfaf120 PMID 41536569 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  3. Histopathological predictors of renal outcomes in idiopathic membranous nephropathy with a focus on global sclerotic glomeruli ratio

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-61455-0 PMID 42706286 Frei zugänglicher VolltextQuelle: OpenAlex

  4. Prognostic value of the ratio of globally sclerotic glomeruli in patients with idiopathic IgA nephropathy

    Scientific Reports, 2026

    DOI 10.1038/s41598-025-33114-3 PMID 41501143 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  5. Sex Differences in Baseline Characteristics and Long-Term Outcomes of Primary Glomerular Diseases: Insights from the TSN-GOLD Registry

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15114017 PMID 42278877 Frei zugänglicher VolltextQuelle: OpenAlex

  6. Real-world epidemiology and renal outcomes of ADPKD in Türkiye: the PKD-TURK cohort

    BMC nephrology, 2026

    DOI 10.1186/s12882-026-05217-0 PMID 42902287 Frei zugänglicher VolltextQuelle: Europe PMC

  7. Additional file 1 of Real-world epidemiology and renal outcomes of ADPKD in Türkiye: the PKD-TURK cohort

    Figshare, 2026

    DOI 10.6084/m9.figshare.34722363 Frei zugänglicher VolltextQuelle: OpenAlex

  8. Additional file 2 of Real-world epidemiology and renal outcomes of ADPKD in Türkiye: the PKD-TURK cohort

    Figshare, 2026

    DOI 10.6084/m9.figshare.34722366 Frei zugänglicher VolltextQuelle: OpenAlex

  9. Association Between SGLT2 Inhibitor Use and Post-Contrast Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Multicenter Cohort Study

    medRxiv, 2026

    DOI 10.64898/2026.02.20.26346726 Frei zugänglicher VolltextQuelle: ORCID

  10. Post-COVID-19 Outcomes of Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Controlled Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15051850 PMID 41827265 Frei zugänglicher VolltextQuelle: ORCID

  11. Burden and correlates of anemia in IgA nephropathy versus other primary glomerulonephritides

    BMC Nephrology, 2026

    DOI 10.1186/s12882-026-05085-8 PMID 42271288 Frei zugänglicher VolltextQuelle: OpenAlex

  12. Could Low Altitude Predict the Use of Erythropoietin-Stimulating Agents in Hemodialysis Patients?

    Therapeutic Apheresis and Dialysis, 2025

    DOI 10.1111/1744-9987.70075 PMID 40855930 Quelle: ORCID

  13. DİYABET GÜÇLENDİRME ÖLÇEĞİ-KISA FORMUNUN HEMODİYALİZ HASTALARINA VE TÜRKÇEYE UYARLANMASI: GEÇERLİLİK VE GÜVENİLİRLİK ÇALIŞMASI

    Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 2025

    DOI 10.37989/gumussagbil.1459025 Frei zugänglicher VolltextQuelle: ORCID

  14. Protective Effect of Sglt2 Inhibitors on Post-contrast Medium Induced Acute Kidney Injury in Diabetic Patients

    Research Square, 2025

    DOI 10.21203/rs.3.rs-8264254/v1 Frei zugänglicher VolltextQuelle: OpenAlex

  15. Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group

    Renal Failure, 2024

    DOI 10.1080/0886022x.2024.2341787 PMID 38637275 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  16. Post-COVID-19 Outcomes of Patients with Primary Glomerular Diseases: A Nationwide Controlled Study

    Turkish Journal of Nephrology, 2024

    DOI 10.5152/turkjnephrol.2024.22480 Frei zugänglicher VolltextQuelle: OpenAlex

  17. Investigation of the Factors Influencing the Response to Hepatitis B Immunization in Patients Undergoing Dialysis Treatment

    Türk Mikrobiyoloji Cemiyeti Dergisi, 2024

    DOI 10.54453/tmcd.2024.37650 Frei zugänglicher VolltextQuelle: OpenAlex

  18. #4052 IMMUNOSUPPRESSIVE TREATMENT RESULTS IN PATIENTS WITH PRIMARY IGA NEPHROPATHY IN TURKIYE: A NATIONWIDE STUDY

    Nephrology Dialysis Transplantation, 2023

    DOI 10.1093/ndt/gfad063c_4052 Quelle: OpenAlex

  19. Trends of primary glomerular disease in Turkey: TSN-GOLD registry report

    International Urology and Nephrology, 2022

    DOI 10.1007/s11255-022-03123-6 PMID 35107695 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  20. Serum soluble Fas-ligand levels and flow-mediated vasodilation in patients undergoing peritoneal dialysis

    Ukrainian Journal of Nephrology and Dialysis, 2022

    DOI 10.31450/ukrjnd.2(74).2022.04 Frei zugänglicher VolltextQuelle: ORCID

  21. Post-COVID-19 outcomes of non-dialysis dependent chronic kidney disease patients: a national, multicenter, controlled study

    International Urology and Nephrology, 2022

    DOI 10.1007/s11255-022-03329-8 PMID 35951255 9 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  22. Evaluation of Outcomes of Peritoneal Dialysis Patients in the Post-COVID-19 Period: A National Multicenter Case-Control Study from Turkey

    The Nephron journals/Nephron journals, 2022

    DOI 10.1159/000526234 PMID 36183694 6 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  23. Characteristics and Survival Results of Peritoneal Dialysis Patients Suffering from COVID-19 in Turkey: A Multicenter National Study

    Kidney & Blood Pressure Research, 2022

    DOI 10.1159/000526909 PMID 36099904 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  24. MO698: Evaluation of Outcomes of Peritoneal Dialysis Patients in the Post-Covid-19 Period: a National Multicenter Case–Control Study from Turkey

    Nephrology Dialysis Transplantation, 2022

    DOI 10.1093/ndt/gfac078.035 Quelle: OpenAlex

  25. MO696: Characteristics and Survival Results of Peritoneal Dialysis Patients Suffering from Covid-19 in Turkey: A Multicenter National Study

    Nephrology Dialysis Transplantation, 2022

    DOI 10.1093/ndt/gfac078.033 Frei zugänglicher VolltextQuelle: OpenAlex

  26. EVALUATION OF OUTCOMES OF PERITONEAL DIALYSISPATIENTS IN THE POST-COVID-19 PERIOD: A NATIONALMULTICENTER CASE–CONTROL STUDY FROM TURKEY

    Çanakkale Onsekiz Mart University AVESIS, 2022

    Quelle: OpenAlex

  27. CHARACTERISTICS AND SURVIVAL RESULTS OF PERITONEALDIALYSIS PATIENTS SUFFERING FROM COVID-19 IN TURKEY:A MULTICENTER NATIONAL STUDY

    Çanakkale Onsekiz Mart University AVESIS, 2022

    Quelle: OpenAlex

  28. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: A nationwide analysis from Turkey

    Nephrology Dialysis Transplantation, 2021

    DOI 10.1093/ndt/gfaa271 PMID 33275763 164 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  29. Serum undercarboxylated osteocalcin levels are related to bone disease in hemodialysis and peritoneal dialysis patients

    The European Research Journal, 2021

    DOI 10.18621/eurj.734216 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  30. Increased QT Dispersion and High Risk of Ventricular Arrhythmias is Associated with Hyperuricemia in Individuals with Normal Renal Function

    Journal of Cardiovascular Emergencies, 2021

    DOI 10.2478/jce-2021-0011 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  31. TÜRKİYE’DE COVID-19 GEÇİREN PERİTON DİYALİZİ HASTALARININ ÖZELLİKLERİ VE SAĞKALIM SONUÇLARI: ÇOK MERKEZLİ ULUSAL ÇALIŞMA

    Kocaeli Üniversitesi - AVESİS, 2021

    Quelle: OpenAlex

  32. P0431TRENDS OF PRIMARY GLOMERULAR DISEASE IN TURKEY FROM 2009 TO 2017: A REGIONAL REGISTRY REPORT FROM TSN-GOLD WORKING GROUP

    Nephrology Dialysis Transplantation, 2020

    DOI 10.1093/ndt/gfaa142.p0431 Quelle: OpenAlex

  33. P0377THE RELATIONSHIP BETWEEN SEVERITY OF INTERSTITIAL FIBROSIS AND ANEMIA IN PATIENT WITH PRIMARY GLOMERULONEPHRITIS: THE DATA FROM TSN-GOLD WORKING GROUP

    Nephrology Dialysis Transplantation, 2020

    DOI 10.1093/ndt/gfaa142.p0377 Frei zugänglicher VolltextQuelle: ORCID

  34. THE RELATIONSHIP BETWEEN SEVERITY OF INTERSTITIAL FIBROSIS AND ANEMIA IN PATIENT WITH PRIMARY GLOMERULONEPHRITIS: THE DATA FROM TSN-GOLD WORKING GROUP

    Bursa Uludag University - AVESIS, 2020

    Quelle: ORCID

  35. HASTANEDE YATAN COVİD-19’LU KBH, HD VE BÖBREK NAKİLLİLERİN BÖBREK HASTALIĞI OLMAYAN COVİD-19’LULARA GÖRE MORTALİTE ANALİZİ

    Kocaeli Üniversitesi - AVESİS, 2020

    Quelle: OpenAlex

  36. Epidemiological features of primary glomerular disease in Turkey: a multicenter study by the Turkish Society of Nephrology Glomerular Diseases Working Group

    BMC Nephrology, 2020

    DOI 10.1186/s12882-020-02134-8 PMID 33189135 27 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  37. P0501THE EPIDEMIOLOGICAL FEATURES OF PIRMARY GLOMERULAR DISEASES IN TURKEY: THE MULTICENTER STUDY OF TURKISH SOCIETY OF NEPHROLOGY GLOMERULAR DISEASES (TSN-GOLD) WORKING GROUP

    Nephrology Dialysis Transplantation, 2020

    DOI 10.1093/ndt/gfaa142.p0501 Quelle: OpenAlex

  38. TRENDS OF PRIMARY GLOMERULAR DISEASE IN TURKEY FROM 2009 TO 2017: A REGIONAL REGISTRY REPORT FROM TSN-GOLD WORKING GROUP

    Bursa Uludag University - AVESIS, 2020

    Quelle: OpenAlex

  39. THE EPIDEMIOLOGICAL FEATURES OF PIRMARY GLOMERULAR DISEASES IN TURKEY: THE MULTICENTER STUDY OF TURKISH SOCIETY OF NEPHROLOGY GLOMERULAR DISEASES (TSN-GOLD) WORKING GROUP

    Bursa Uludag University - AVESIS, 2020

    Quelle: OpenAlex

  40. Türkiye’de primer glomerulonefritlerin yıllara göre değişimi

    2019

    Quelle: OpenAlex

  41. Role of Local Renin Angiotensin System Activation on Blood Pressure and Residual Renal Function in Peritoneal Dialysis Patients

    Turkish Journal of Nephrology, 2019

    DOI 10.5152/turkjnephrol.2019.3101 Frei zugänglicher VolltextQuelle: OpenAlex

  42. Türkiye’xxde Primer Glomerüler Hastalıkların Epidemiyolojik Özellikleri

    2019

    Quelle: OpenAlex

  43. Primer Glomerüler hastalıkların tanı ve tedavisi: Türk nefroloji derneği ulusal uzlaşı raporu

    2019

    Quelle: OpenAlex

  44. Türkiye’de primer glomerüler hastalıkların epidemiyolojik özellikleri

    Bursa Uludag University - AVESIS, 2019

    Quelle: OpenAlex

  45. Primer Glomerüler hastalıkların tanı ve tedavisi: Türk nefroloji derneği ulusal uzlaşı raporu

    Kocaeli Üniversitesi - AVESİS, 2019

    Quelle: OpenAlex

  46. Türkiye’de Primer Glomerülonefritlerin Yıllara Göre Değişimi

    Kocaeli Üniversitesi - AVESİS, 2019

    Quelle: OpenAlex

  47. Comparison of Widely Used Biochemical Analytes in the Serum and Saliva Samples of Dialysis Patients

    Journal of Medical Biochemistry, 2018

    DOI 10.1515/jomb-2017-0056 PMID 30598632 16 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  48. Serum Neuron Specific Enolase and S-100B Levels in Hemodialysis and Peritoneal Dialysis Patients

    European Archives of Medical Research, 2018

    DOI 10.4274/eamr.galenos.2018.46338 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  49. Is There Any Contribution of Pancreatic Exocrine Dysfunction to the Malnutrition in Chronic Kidney Disease and End Stage Renal Disease?

    Kafkas Journal of Medical Sciences, 2018

    DOI 10.5505/kjms.2018.74317 2 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  50. TÜRKİYE’DE PRİMER FOKAL SEGMENTAL GLOMERÜLOSKLEROZ: TÜRK NEFROLOJİ DERNEĞİ ULUSAL KAYIT SİSTEMİ VERİLERİ

    2018

    Quelle: OpenAlex